What question did this study set out to answer?

The aim is to investigate how smoking and vascular risk factors affect relapse rates in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).

April 10, 2026Open Access

Myelin oligodendrocyte glycoprotein antibody-associated disease and relapse risk: Effects of smoking and vascular risk factors

Read Full Paperexternally

Key Points

The aim is to investigate how smoking and vascular risk factors affect relapse rates in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Compared relapse rates among current, past, and never smokers
Analyzed the association of vascular risk factors with relapse risk
Relapse rates were doubled in current smokers compared to never smokers
Past smokers did not show a significant difference in relapse rates from never smokers
Vascular risk factors did not show an association with relapse risk

Abstract

Relapse rates were doubled in current than never smokers, whereas these were similar between past and never smokers. VRF did not associate with relapse risk. Smoking cessation should be encouraged in current smokers with MOGAD as past smokers were not observed with this poorer outcome.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Wei Zhen Yeh

Fiona Chan

Anna Francis

Journals

Multiple Sclerosis Journal

Actions

Institutions

Monash University

John Radcliffe Hospital

Alfred Health

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Myelin oligodendrocyte glycoprotein antibody-associated disease and relapse risk: Effects of smoking and vascular risk factors

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study